Point72 Asset Management L.P. Makes New Investment in DaVita Inc. (NYSE:DVA)

Point72 Asset Management L.P. bought a new position in DaVita Inc. (NYSE:DVA) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 69,388 shares of the company’s stock, valued at approximately $9,615,000. Point72 Asset Management L.P. owned 0.08% of DaVita as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. SG Americas Securities LLC grew its holdings in shares of DaVita by 196.9% in the first quarter. SG Americas Securities LLC now owns 29,733 shares of the company’s stock worth $4,105,000 after purchasing an additional 19,719 shares during the last quarter. Bessemer Group Inc. grew its stake in DaVita by 2,335.6% in the first quarter. Bessemer Group Inc. now owns 10,741 shares of the company’s stock worth $1,483,000 after purchasing an additional 10,300 shares in the last quarter. Forsta AP Fonden increased its holdings in DaVita by 50.3% during the 1st quarter. Forsta AP Fonden now owns 23,600 shares of the company’s stock worth $3,258,000 after purchasing an additional 7,900 shares during the period. Fox Hill Wealth Management raised its position in DaVita by 138.4% during the 1st quarter. Fox Hill Wealth Management now owns 15,734 shares of the company’s stock valued at $2,172,000 after purchasing an additional 9,135 shares in the last quarter. Finally, Sei Investments Co. lifted its holdings in shares of DaVita by 21.3% in the 1st quarter. Sei Investments Co. now owns 41,952 shares of the company’s stock worth $5,790,000 after buying an additional 7,371 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Trading Up 0.5 %

NYSE:DVA opened at $163.93 on Tuesday. The company has a current ratio of 1.16, a quick ratio of 1.12 and a debt-to-equity ratio of 9.94. The firm has a fifty day simple moving average of $150.62 and a 200-day simple moving average of $142.34. DaVita Inc. has a 12 month low of $71.51 and a 12 month high of $166.04. The company has a market capitalization of $13.75 billion, a P/E ratio of 18.63, a PEG ratio of 0.93 and a beta of 0.87.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share for the quarter, beating the consensus estimate of $2.47 by $0.12. The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.15 billion. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.08 EPS. On average, equities research analysts anticipate that DaVita Inc. will post 9.99 earnings per share for the current year.

Analyst Ratings Changes

Several analysts recently weighed in on the company. UBS Group lifted their price objective on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Truist Financial upped their price objective on DaVita from $150.00 to $165.00 and gave the stock a “hold” rating in a research note on Tuesday, August 20th. TD Cowen lifted their price target on shares of DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. Bank of America increased their price objective on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a report on Wednesday, August 7th. Finally, StockNews.com lowered DaVita from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $157.00.

Insiders Place Their Bets

In related news, CEO Javier Rodriguez sold 50,000 shares of the firm’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the completion of the transaction, the chief executive officer now owns 837,835 shares of the company’s stock, valued at $138,284,666.75. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CFO Joel Ackerman sold 64,029 shares of the company’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total value of $9,928,336.74. Following the sale, the chief financial officer now owns 111,481 shares in the company, valued at $17,286,243.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $165.05, for a total value of $8,252,500.00. Following the transaction, the chief executive officer now owns 837,835 shares of the company’s stock, valued at $138,284,666.75. The disclosure for this sale can be found here. In the last ninety days, insiders sold 173,482 shares of company stock valued at $27,387,069. 2.00% of the stock is owned by insiders.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.